<9> Virulence of Group A Streptococci Is Enhanced by Human Complement Inhibitors
Virulence of Group A
Streptococci Is Enhanced by Human Complement Inhibitors
David
Ermert, Jutamas
Shaughnessy, Thorsten Joeris, Jakub Kaplan, Catherine
J. Pang, Evelyn A. Kurt-Jones, Peter A. Rice, Sanjay Ram, Anna M. Blom
Plos Pathogen, 11: e1005043. July 22,
2015
Speaker: Meng-Ju Tsai (蔡孟儒) Time: 15:00~16:00, Oct. 07, 2015
Commentator: Dr. Pei-Jan
Tsai (蔡佩珍老師) Place: Room 601
Abstract:
Streptococcus pyogenes, also
known as Group A Streptococcus (GAS), is an important human bacterial pathogen
that can cause a spectrum of disease, ranging from milder pharyngitis to
severer invasive infection. To overcome innate immune defense mechanism,
including opsonization by complement and consequent phagocytosis, GAS produces
several virulence factors that interact with human proteins. Among them are the
M protein family members which interact with human C4b binding protein (C4BP) and
human Factor H (FH), and curtail complement C3 deposition on bacterial surface to
diminish activation of phagocytes [1, 2]. However, several GAS strains do not
bind mouse complement inhibitors and, therefore, the wild type mouse models are
not suitable for these strains and the in vivo evidence has been lacking. To
solve this problem, the authors generated three transgenic mouse models which
expressed either human C4BP or human FH, or both complement inibitors
(C4BPxFH). Compared to the wild type mouse, these three transgenic mice showed
higher mortality, with the C4BPxFH mouse showing highest mortality, after
infection by AP1, a strain that produces M protein and another M protein family
member, protein H. Further, a mutant deficient in both the M protein and
protein H showed reduced virulence in the C4BPxFH mouse. These results suggest
that the bound C4BP and FH might enhanced the virulence of AP1 in the
transgenic mice. The AP1-infected C4BPxFH mice had higher organism burdens and exhibited
greater elevations of pro-inflammatory cytokines and this may explain why they
died earlier than the wild type mouse. Consistently, the strains of GAS whose M
protein did not bind the inhibitors showed similar mortality in the wild type
and C4BPxFH mice. Taken together, the binding of C4BP and FH is important for
GAS to impair opsonization and evade phagoctosis. These mouse models may prove
invaluable in studies of GAS pathogenesis and also for developing therapeutics.
References:
1.
Thern A, Stenberg L, Dahlback
B, Lindahl G (1995). Ig-binding surface proteins of Streptococcus pyogenes also bind human
C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol. 154:375–386.
2.
Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA. (1988).
Antiphagocytic activity of streptococcal M protein:
selective binding of complement control protein factor H. Proc Natl Acad Sci
U S A. 85:1657–1661.